What if Ozempic only cost $50 a month?
Millions more people would finally have access to effective weight-loss and diabetes meds:
This shift is coming fast—and it starts in Canada.
Right now, Ozempic and similar drugs cost $200–$400 per month in Canada. In the U.S., it’s around $1,000.
That puts them out of reach for many.
But in 2026, Sandoz plans to launch a generic semaglutide at $40–$50 per month after the patent expires.
That price cut could triple the number of people using these drugs.
In BC alone, up to 15% of Ozempic prescriptions already go to Americans crossing the border to get cheaper meds.
If this generic hits the market, the ripple effect across North America could be huge.
Lower-cost generics would:
- Ease pressure on Canadian pharmacies
- Expand access for people managing diabetes and obesity
- Save U.S. insurers and patients billions
Florida has already been approved to import Canadian meds. Others are lining up.
The key question now:
Will U.S. regulators move fast enough to let Americans access these affordable generics?
One thing’s clear—2026 could redefine what affordable care looks like.
Are you ready for the shift?